Answers are grounded in this paper and cite their sources.
Population-based study reports increased incidence of therapy-related acute myeloid leukemia, indicating growing concerns about its burden post-cancer treatment.
There was a gradual increase in the annual tAML incidence and a change in the distribution of primary cancers. These findings suggest an emerging concern regarding the burden of tAML as a post-cancer therapy complication.
No takes yet. Share an insight, caveat, or question.
Kishimoto et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: